Your session is about to expire
← Back to Search
This trial will test a new type of radiation (SBRT) to treat prostate cancer with fewer side effects than standard treatments. Participants will have scans and blood tests, receive radiation in two sessions, then be followed-up for two years.
- Prostate Cancer
- Prostate Adenocarcinoma
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What potential risks could be associated with 1/Focal SBRT treatments?
"We assign a safety score of 2 to 1/Focal SBRT, as phase two trials only provide evidence for the drug's security and not its efficacy."
Has recruitment for this experiment begun?
"As indicated on clinicaltrials.gov, this medical investigation is no longer actively seeking participants; the initial posting was made on November 29th 2022 with the latest update being logged eleven days prior. However, there are over two thousand other trials that still require volunteers at present."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
What state do they live in?
Share this study with friends